News

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go.

Dangouloff T, Vrščaj E, Servais L, Osredkar D; SMA NBS World Study Group. Neuromuscul Disord. 2021 Apr 7:S0960-8966(21)00071-7.

17 aprile 2021

Muscle Stem Cell Quiescence: Controlling Stemness by Staying Asleep.

Ancel S, Stuelsatz P, Feige JN. Trends Cell Biol. 2021 Mar 2:S0962-8924(21)00031-3.

15 aprile 2021

Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy.

Luan P, D'Amico D, Andreux PA, Laurila PP, Wohlwend M, Li H, Imamura de Lima T, Place N, Rinsch C, Zanou N, Auwerx J. Sci Transl Med. 2021 Apr 7;13(588):eabb0319.

07 aprile 2021

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD.

Schmitz A, Pinheiro Marques J, Oertig I, Maharjan N, Saxena S. Front Cell Neurosci. 2021 Feb 18;15:637548

01 aprile 2021

The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.

Moisse M, Zwamborn RAJ, van Vugt J, van der Spek R, van Rheenen W, Kenna B, Van Eijk K, Kenna K, Corcia P, Couratier P, Vourc'h P, Hardiman O, McLaughin R, Gotkine M,...

25 marzo 2021

An in vitro reconstituted U1 snRNP allows the study of the disordered regions of the particle and the interactions with proteins and ligands.

Campagne S, de Vries T, Malard F, Afanasyev P, Dorn G, Dedic E, Kohlbrecher J, Boehringer D, Cléry A, Allain FH. Nucleic Acids Res. 2021 Mar 2

15 marzo 2021

Early detection of evolving critical illness myopathy with muscle velocity recovery cycles.

Tankisi A, Pedersen TH, Bostock H, Z'Graggen WJ, Larsen LH, Meldgaard M, Elkmann T, Tankisi H. Clin Neurophysiol. 2021 Feb 20:S1388-2457(21)00050-X.

05 marzo 2021

<< Prima < Precedente 71-80 81-90 91-100101-110111-120 121-130 131-140 Prossima >Ultima >>

News

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go.

Muscle Stem Cell Quiescence: Controlling Stemness by Staying Asleep.

Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy.

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD.

The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.

An in vitro reconstituted U1 snRNP allows the study of the disordered regions of the particle and the interactions with proteins and ligands.

Early detection of evolving critical illness myopathy with muscle velocity recovery cycles.

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

Genetic neuropathies presenting with CIDP-like features in childhood.

Rapid subcellular calcium responses and dynamics by calcium sensor G-CatchER.

La Fondazione

FSRMM